People | February 04, 2025
Carbogen Amcis appoints Stephan Fritschi as CEO
Pascal Villemagne has announced his intent to step down at the end of March 2025, to take on a new challenge in his professional career.
Pascal Villemagne has announced his intent to step down at the end of March 2025, to take on a new challenge in his professional career.
Our Q3 FY25 revenue was at Rs. 1,384.1 crore with an EBITDA of Rs. 360 crore resulting in a 26% EBITDA margin
Revenue from Operations for Q3 FY25 was Rs. 454.33 crore,
Recommendation based on results of Phase 3 CheckMate -9DW clinical trial demonstrating statistically significant and clinically meaningful improvement in overall survival with Opdivo plus Yervoy compared to investigator’s choice of lenvatinib or sorafenib in this patient population
These solutions combine scientifically or clinically validated, regulatory-approved probiotic strains with precise dosing
Biocon’s subsidiary Biocon Biologics Limited, which also participated independently in the assessment for the first time, reported an S&P Global ESG Score of 53
Mamilli last held the role of Chief Digital & Technology Officer and Group President for China, Brazil and Precision Animal Health at Zoetis
The Emcure Research Centre (ERC) will drive research across multiple dosage forms, including OSD, injectables, novel drug delivery systems (NDDS), inhalers and topical and transdermal formulations
Scored 85/100, 2.3x the industry average in Social and 73/100, 1.8x the industry average in Governance
The company has paid an Interim Environmental Damage Compensation of Rs. 3.40 lakh to GPCB
Subscribe To Our Newsletter & Stay Updated
